Related Experiment Video
Updated: Jul 12, 2025
A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
Published on: September 16, 2022
Biofilm Formation in Medically Important Candida Species
Zuzana Malinovská1, Eva Čonková1, Peter Váczi1
1Department of Pharmacology and Toxicology, University of Veterinary Medicine and Pharmacy, Komenského 73, 041 81 Košice, Slovakia.
Abstract:
Worldwide, the number of infections caused by biofilm-forming fungal pathogens is very high. In human medicine, there is an increasing proportion of immunocompromised patients with prolonged hospitalization, and patients with long-term inserted drains, cannulas, catheters, tubes, or other artificial devices, that exhibit a predisposition for colonization by biofilm-forming yeasts. A high percentage of mortality is due to candidemia caused by medically important Candida species. Species of major clinical significance include C. albicans, C. glabrata, C. tropicalis, C. parapsilosis, C. krusei, and C. auris. The association of these pathogenic species in the biofilm structure is a serious therapeutic problem. Candida cells growing in the form of a biofilm are able to resist persistent therapy thanks to a combination of their protective mechanisms and their ability to disseminate to other parts of the body, thus representing a threat from the perspective of a permanent source of infection. The elucidation of the key mechanisms of biofilm formation is essential to progress in the understanding and treatment of invasive Candida infections.
Insights
Biofilm-forming yeasts, particularly Candida species, cause widespread infections, especially in vulnerable patients. Understanding biofilm formation is crucial for treating these persistent and life-threatening fungal infections.
Area of Science:
- Mycology
- Infectious Diseases
- Medical Microbiology
Background:
- Biofilm-forming fungal pathogens cause numerous infections globally.
- Immunocompromised patients and those with indwelling medical devices are at high risk for yeast colonization.
- Candidemia, often caused by medically significant Candida species, has a high mortality rate.
Purpose of the Study:
- To highlight the therapeutic challenges posed by pathogenic yeasts forming biofilms.
- To emphasize the importance of understanding biofilm formation mechanisms in invasive Candida infections.
Main Methods:
- Review of current literature on fungal biofilms and Candida infections.
- Analysis of the clinical significance of various Candida species.
- Discussion of the protective mechanisms employed by Candida biofilms.
Main Results:
- Candida species form biofilms that are resistant to antifungal therapy.
- Biofilm-associated infections represent a persistent source of infection and dissemination.
- Key Candida species include C. albicans, C. glabrata, C. tropicalis, C. parapsilosis, C. krusei, and C. auris.
Conclusions:
- Elucidating the mechanisms of biofilm formation is essential for developing effective treatments.
- Targeting biofilm formation is critical for managing invasive Candida infections and reducing mortality.
More Related Videos
11:14Visualization of Biofilm Formation in Candida albicans Using an Automated Microfluidic Device
Published on: December 14, 2017
08:31Candida albicans Biofilm Development on Medically-relevant Foreign Bodies in a Mouse Subcutaneous Model Followed by Bioluminescence Imaging
Published on: January 27, 2015
Related Concept Videos
01:29Biofilms
01:29Fungal Group Zygomycota